Analysis of Botulinum Toxin Products and Litigation in the United States

Author： Korman John B. Jalian H. Ray Avram Mathew M.

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.39, Iss.11, 2013-11, pp. : 1587-1591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Botulinum Toxin

By FULTON TAMES E.

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1219-1224

Elsevier

Access to resources Recommend Favorite

Consistent Biochemical Data are Essential for Comparability of Botulinum Toxin Type A Products

By Pickett Andy

Drugs in R&D, Vol. 11, Iss. 1, 2011-03 ,pp. : 97-98

Adis International

Access to resources Recommend Favorite

The therapeutic use of botulinum toxin

By Tugnoli V. Eleopra R. Montecucco C. de Grandis D.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1383-1394

Informa Healthcare

Access to resources Recommend Favorite

Understanding Botulinum Toxin

By WIEDER JOSHUA M. MOY RONALD L.

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1172-1174

Elsevier

Access to resources Recommend Favorite

Dilution and Storage of Botulinum Toxin

By KLEIN ARNOLD W.

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1179-1180

Elsevier

Access to resources Recommend Favorite